The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Alexza Pharmaceuticals Inc | COM | 015384100 | 1,736 | 399,999 | SH | SOLE | 0 | 399,999 | 0 | 0 | |
Anacor Pharmaceuticals Inc | COM | 032420101 | 9,005 | 1,610,856 | SH | SOLE | 0 | 1,610,856 | 0 | 0 | |
Anthera Pharmaceuticals Inc | COM | 03674U102 | 666 | 1,437,623 | SH | SOLE | 0 | 1,437,623 | 0 | 0 | |
BioCryst Pharmaceuticals Inc | COM | 09058V103 | 1,571 | 1,013,442 | SH | SOLE | 0 | 1,013,442 | 0 | 0 | |
Biodel Inc | COM | 09064M105 | 6,046 | 1,446,413 | SH | SOLE | 0 | 1,446,413 | 0 | 0 | |
Chelsea Therapeutics International Ltd | COM | 163428105 | 5,789 | 2,516,870 | SH | SOLE | 0 | 2,516,870 | 0 | 0 | |
Dyax Corp | COM | 26746E103 | 14,382 | 4,156,508 | SH | SOLE | 0 | 4,156,508 | 0 | 0 | |
GTx Inc | COM | 40052B108 | 3,300 | 500,000 | SH | SOLE | 0 | 500,000 | 0 | 0 | |
GW Pharmaceuticals | COM | 36197T103 | 7,381 | 837,800 | SH | SOLE | 0 | 837,800 | 0 | 0 | |
Hyperion Therapeutics Inc | COM | 44915N101 | 5,610 | 255,000 | SH | SOLE | 0 | 255,000 | 0 | 0 | |
Ironwood Pharmaceuticals Inc | COM | 46333X108 | 17,874 | 1,800,000 | SH | SOLE | 0 | 1,800,000 | 0 | 0 | |
Keryx Biopharmaceuticals Inc | COM | 492515101 | 15,304 | 2,048,773 | SH | SOLE | 0 | 2,048,773 | 0 | 0 | |
Neurocrine Biosciences Inc | COM | 64125C109 | 26,287 | 1,964,673 | SH | SOLE | 0 | 1,964,673 | 0 | 0 | |
Stemline Therapeutics Inc | COM | 85858C107 | 1,192 | 50,000 | SH | SOLE | 0 | 50,000 | 0 | 0 | |
TESARO Inc | COM | 881569107 | 8,549 | 261,130 | SH | SOLE | 0 | 261,130 | 0 | 0 | |
Threshold Pharmaceuticals Inc | COM | 885807206 | 3,598 | 684,000 | SH | SOLE | 0 | 684,000 | 0 | 0 | |
Vanda Pharmaceuticals Inc | COM | 921659108 | 6,363 | 787,459 | SH | SOLE | 0 | 787,459 | 0 | 0 |